InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Suri Anish, Président et Directeur Scientifique. Insider active across 1 companies, notably Cue Biopharma, Inc.. Cumulatively, 9 disclosures have been logged. The latest transaction was filed on 15 November 2021 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations9 total
16,668 shares
Common Stock
SEC:0001209191-22-022578:0·
€57,7548,000 shares@ €7.219220.7% of flow
Common Stock
SEC:0000899243-21-045069·
€57,7548,000 shares@ €7.21920.20% mcap10.4% of flow
Common Stock
SEC:0000899243-21-045069:0·
€111,78920,000 shares@ €5.589440.1% of flow
Common Stock
SEC:0000899243-21-044603·
€111,78920,000 shares@ €5.58940.38% mcap20.0% of flow
Common Stock
SEC:0000899243-21-044603:0·
33,334 shares
Common Stock
SEC:0001209191-21-060021·
33,334 shares
Common Stock
SEC:0001209191-21-060021:0·
€109,36720,000 shares@ €5.468439.2% of flow
Common Stock
SEC:0001209191-21-057785·
€109,36720,000 shares@ €5.46840.37% mcap19.6% of flow
Common Stock
SEC:0001209191-21-057785:0·
9 of 9 declarations
About Suri Anish
Anish Suri is the President and Chief Scientific Officer at Cue Biopharma, Inc. He leads the company's research and development efforts, focusing on innovation in the field of biotherapies. His scientific expertise is crucial for the development of new therapeutic solutions and for the strategic direction of the company.
